CPAP treatment and metabolism in women with PCOS and sleep apnea
Looks at how CPAP affects cell metabolism in adults with PCOS and sleep apnea.
Key facts
- Who runs it
- University of Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- PMOS in OSA Pilot Study
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- Oct 2026
- Expected to end
- Oct 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Continuous Positive Airway Pressure (CPAP)
- Record updated
- 13 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18-40 with PMOS (Polyendocrine Metabolic Ovarian Syndrome) and sleep apnea. It studies how sleep apnea affects cell energy and metabolism.
- Age
- 18 to 40 years
- Sex
- Women only
- Disease stage
- PMOS diagnosis plus sleep apnea (AHI>5) found by a home sleep test (WatchPAT One).
- Earlier treatment
- People who regularly use CPAP as clinical guidelines advise cannot join.
- Biomarker or test result
- AHI>5 on a home sleep test (WatchPAT One). BMI below 50.0. Hemoglobin must not be below 11.6 g/dL.
Main reasons for not taking part
- Regular CPAP use as clinical guidelines advise
- Any bleeding disorder, or current use of anti-coagulant medication
- Hemoglobin below 11.6 g/dL
- Pregnant now, pregnant within the last year, or gave birth within the last year
- Serious heart, lung, kidney, liver, thyroid or other illness, or cancer treated in the past 5 years
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Women 18-40 years old
- PMOS diagnosis
- Sleep Apnea (AHI>5) diagnosed by home sleep test (WatchPAT One)
- BMI< 50.0
Who cannot take part
- Current use of anti-coagulant medication
- Any history of bleeding disorders
- Any underlying disease likely to limit life span and/or increase risk of interventions including cardiovascular disease (e.g. unstable angina, heart failure requiring hospitalization in the past 6 months, significant heart block or arrhythmias, NYHA Class>2), pulmonary disease with dependence on oxygen or daily use of bronchodilators, cancer requiring treatment in the past 5 years unless the prognosis is considered good, active or chronic infection, thyroid disease and other endocrine disorders (e.g. Cushing syndrome, acromegaly), hepatitis or other chronic gastrointestinal disease (pancreatitis, inflammatory bowel disease), renal disease, significant anemia, recent surgery or significant abdominal surgery, major psychiatric or any eating disorder, acute coronary syndrome or stroke in the past 6 months
- Hemoglobin <11.6 g/dL
- Regular adherent CPAP use per clinical guidelines
- Currently pregnant, pregnant within the last year, or gave birth within the last year
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
Where in United States
- University of ChicagoChicago, United StatesContact: Bonnie Olivia HughesTaking people
About the trial
What the trial wants to find out
The goal of this study is to obtain pilot data investigating the effects of sleep apnea on mitochondrial function and cellular metabolism in Polyendocrine Metabolic Ovarian Syndrome (PMOS) patients.
The 2 groups in the trial
- TreatedExisting treatment, for comparison
Treated with Continuous Positive Airway Pressure (CPAP).
Treatment: Continuous Positive Airway Pressure (CPAP)
- UntreatedNo study treatment, for comparison
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Metabolic Changes in PMOS Patients With Obstructive Sleep Apnea (OSA) Pilot Study
- Plain-language title
- CPAP treatment and metabolism in women with PCOS and sleep apneaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07871149, who can take part
- Record updated
- 13 October 2026